Related Articles
TUMOR RESPONSE AND 4 YEAR SURVIVAL-DATA OF PATIENTS WITH ADVANCED RENAL-CELL CARCINOMA TREATED WITH AUTOLOGOUS TUMOR VACCINE AND SUBCUTANEOUS R-IL-2 AND IFN-ALPHA(2B)
The efficacy of 2',2'-difluorodeoxycytidine (gemcitabine) and vinblastine combined with interferon in nude mice xenografts of human renal cell carcinoma.
SUBCUTANEOUS RIL-2 IN ADVANCED MELANOMA AND KIDNEY CARCINOMA
RECOMBINANT INTERLEUKIN-2 AND INTERFERON-ALPHA-2A IN PRETREATED ADVANCED SOFT-TISSUE SARCOMAS
IFN-ALPHA THERAPY OF RENAL-CELL CARCINOMA - DEFECT OF LYMPHOCYTE SENSITIVITY TO MITOGENIC AND ACTIVATING CYTOKINE SIGNALS IN PATIENTS NOT-RESPONDING TO THERAPY